Literature DB >> 18951068

Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein.

Varun Agrawal1, Kevin R Krause, David L Chengelis, Kerstyn C Zalesin, Leslie L Rocher, Peter A McCullough.   

Abstract

BACKGROUND: Bariatric surgery achieves long-term weight loss in obese adults with amelioration of diabetes and hypertension. Improvement in albuminuria and high-sensitivity C-reactive protein (hs-CRP) has also been reported. We investigated, at a weight control center in a community hospital setting, the relation between degree of surgical weight loss and reduction in the cardiovascular risk markers, albuminuria and hs-CRP.
METHODS: We performed a retrospective study of 62 obese adults who had undergone Roux-en-Y gastric bypass surgery and had a median follow-up of 15 months.
RESULTS: The baseline (preoperative) mean age was 46 years, 82% were women, 26 had a blood pressure of > or =140/90 mm Hg, and 25 had type 2 diabetes. During follow-up (postoperative), a decrease occurred in the body mass index (mean +/- standard deviation 49.2 +/- 8.7 kg/m(2) to 34.1 +/- 8.1 kg/m(2); P <.0001), excess body weight (mean +/- SD 76.1 +/- 23.6 kg to 34.9 +/- 21.7 kg; P <.0001), hemoglobin A1c (mean +/- SD 6.5% +/- 1.3% to 5.6% +/- 0.8%; P <.0001), systolic blood pressure (mean +/- SD 133.7 +/- 14.3 mm Hg to 112.9 +/- 14.6 mm Hg; P < .0001), urine albumin creatinine ratio (from a median of 8.0 mg/g [interquartile range 5.0-29.3] to a median of 6.0 mg/g [interquartile range 3.3-11.5]; P <.0001), and hs-CRP (mean +/- SD 11.2 +/- 9.8 mg/L to 4.7 +/- 5.9 mg/L; P <.0001). The study sample was divided into tertiles of the percentage of excess body weight loss; the mean percentage of excess body weight loss was -37.1% +/- 5.5% in the first tertile, -54.3% +/- 6.8% in the second tertile, and -75.8% +/- 10.9% in the third tertile. The median percentage of change in albuminuria was greatest (median -52.8%, interquartile range -79.1% to -17.5%) in the third tertile, intermediate (median -45.5%, interquartile range -72.4% to 0%) in the second tertile, and lowest (-42.6%, interquartile range -80.5% to 16.7%) in the first tertile (P = .953). The mean percentage of change in hs-CRP was greatest (-72.4% +/- 30.4%) in the third tertile, intermediate (-55.4% +/- 31.9%) in the second tertile, and lowest (-44.8% +/- 30.6%) in the first tertile (P = .037).
CONCLUSION: The results of our study have shown that obese adults experience a reduction in albuminuria and hs-CRP after bariatric surgery, with a greater reduction in hs-CRP observed with more surgical weight loss.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951068     DOI: 10.1016/j.soard.2008.07.011

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  24 in total

Review 1.  Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.

Authors:  Rikki M Tanner; Todd M Brown; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

2.  Early improvement in albuminuria in non-diabetic patients after Roux-en-Y bariatric surgery.

Authors:  Sumit Mohan; Jennifer Tan; Saritha Gorantla; Leaque Ahmed; Constance M Park
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 3.  Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.

Authors:  Ted D Adams; David E Arterburn; David M Nathan; Robert H Eckel
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

4.  Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up.

Authors:  Valerio Ceriani; Francesco Cetta; Tiziana Lodi; Ferdinando Pinna; Antonio E Pontiroli
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

5.  Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery.

Authors:  Antonio Amor; Amanda Jiménez; Violeta Moizé; Ainitze Ibarzabal; Lílliam Flores; Antonio M Lacy; Josep Vidal
Journal:  Surg Endosc       Date:  2013-01-05       Impact factor: 4.584

Review 6.  Treatment of Obesity: Weight Loss and Bariatric Surgery.

Authors:  Bruce M Wolfe; Elizaveta Kvach; Robert H Eckel
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 7.  Weight loss interventions and progression of diabetic kidney disease.

Authors:  Neil G Docherty; Aoife L Canney; Carel W le Roux
Journal:  Curr Diab Rep       Date:  2015-08       Impact factor: 4.810

Review 8.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

Review 9.  Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.

Authors:  Konstantinos Tziomalos; Hariklia V Dimitroula; Niki Katsiki; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Mediators Inflamm       Date:  2010-03-07       Impact factor: 4.711

10.  The longer-term effects of Roux-en-Y gastric bypass surgery on sodium excretion.

Authors:  Funda Celik; Mohamed Ahdi; Eelco W Meesters; Arnold van de Laar; Dees P M Brandjes; Victor E A Gerdes
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.